Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
Earnings Data
Report Date
Aug 19, 2025TBA Not Confirmed
Period Ending
2026 (Q1)Consensus EPS Forecast
1.23Last Year’s EPS
1.23Same Quarter Last Year
Moderate Buy
Based on 20 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 21, 2025
|% Change Since: -0.96%
|Next Earnings Date:Aug 19, 2025
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with positive revenue growth, especially in Cardiovascular and Neuromodulation segments. The decision to spin off the Diabetes business is seen as a strategic move to focus on higher-margin growth areas. However, concerns about tariff impacts and currency headwinds were noted.Company Guidance
During Medtronic's fiscal year 2025 fourth-quarter earnings call, the company reported a strong 5.4% organic revenue growth, with significant contributions from its Cardiovascular portfolio, which grew by 8%, and double-digit growth in Neuromodulation and Diabetes. The company achieved a high single-digit operating profit and low double-digit EPS growth, with EPS increasing 11% to $1.62 for the quarter. Medtronic announced its plan to separate the Diabetes business into a standalone public company via a capital market separation, aiming for a tax-free impact on shareholders and anticipating improvements in gross and operating margins by 50 and 100 basis points, respectively. For fiscal year 2026, Medtronic expects organic revenue growth of approximately 5% and EPS growth of about 4%, excluding tariffs. The company also highlighted its ongoing strategic focus on high-margin growth markets and new innovations, such as its Cardiac Ablation Solutions, which grew nearly 30%, and plans for the US launch of its Hugo robot and Symplicity hypertension procedure.Strong Revenue Growth
The company reported a 5.4% organic revenue growth in Q4, with notable acceleration in Cardiovascular (8%), Neuromodulation, and Diabetes segments.
Cardiac Ablation Solutions Surge
Cardiac Ablation Solutions grew nearly 30%, driven by high demand for Affera PFA products and the Sphere-9 focal catheter.
Neuromodulation Leads Market
Neuromodulation grew 10%, with a 12% increase in Pain Stim and 15% growth in the US, maintaining the number one global position in SCS.
Diabetes Segment Growth
The Diabetes segment achieved 12% growth, marking the sixth consecutive quarter of double-digit growth, with strong contributions from the MiniMed 780G and Simplera Sync sensor.
Significant Operational Leverage
The company achieved high single-digit operating profit and low double-digit EPS growth, with Q4 EPS growth of 11%.
Portfolio Milestones
Two businesses, CAS and ENT, reached $1 billion in annual revenue, joining ten other businesses in this category.
Separation of Diabetes Business
The decision to separate the Diabetes business into a standalone public company is seen as a strategic move for focused growth and investment.
MDT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
MDT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 21, 2025 | $86.37 | $84.41 | -2.27% |
Feb 18, 2025 | $92.08 | $85.39 | -7.27% |
Nov 19, 2024 | $86.16 | $83.61 | -2.96% |
Aug 20, 2024 | $82.78 | $83.32 | +0.65% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Medtronic (MDT) report earnings?
Medtronic (MDT) is schdueled to report earning on Aug 19, 2025, TBA Not Confirmed.
What is Medtronic (MDT) earnings time?
Medtronic (MDT) earnings time is at Aug 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MDT EPS forecast?
MDT EPS forecast for the fiscal quarter 2026 (Q1) is 1.23.
